CTOs on the Move


 
Ivenix, Inc. is a venture-backed medical device company with a vision to transform infusion delivery in every care setting, globally. The company is focused on bringing its first product to market, a new and innovative infusion management system for hospitals. The system combines integrated state-of-the-art information technology and simplicity with an adaptive fluid delivery platform that continuously measures flow. The company is headquartered in Amesbury, Massachusetts.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.ivenix.com
  • 21 Water St
    Amesbury, MA USA 01913
  • Phone: 978.792.5000

Executives

Name Title Contact Details

Funding

Ivenix raised $42M on 09/01/2015

Similar Companies

RPS ReSearch Pharmaceutical Services

In 1998, RPS began building the foundation for the PRO model in anticipation of evolving clinical strategies within Sponsor companies. By integrating its personnel and systems with those of Sponsor companies, RPS has helped industry leaders achieve significant cost savings, flexible program staffing, and standardized system operations on a global scale.

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.

Stop Heart Attack Dot Com

Stop Heart Attack Dot Com is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Scarborough Community Care Access Centre

Scarborough Community Care Access Centre is a Scarborough, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mercy Retirement and Care Center

Mercy Retirement and Care Center, a nonprofit organization, has been providing quality compassionate care and services to older adults for more than 130 years. Supportive residential, assisted living, dementia care and skilled nursing programs are offered